Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Eyebot
AddedFeb 17, 2024
UpdatedJun 18, 2026
Eyebot

Eyebot

Pre-Seed

Eyebot: Innovating rapid eye exam technology for accessible vision care.

HQ
Boston, MA, US
Founded
2021
Overview
Compare
Fundraising
Employees
News
Website

Founded with a mission to revolutionize vision care, Eyebot focuses on developing rapid eye examination technologies that make vision care more accessible. Their innovative solutions aim to eliminate traditional barriers to obtaining eye exams, ensuring that more people can maintain their eye health without the usual constraints of time and accessibility. By leveraging cutting-edge technology, Eyebot is positioned to serve a broad market, including underserved communities and regions with limited access to traditional eye care services.

Eyebot has attracted notable investors and industry experts who believe in their mission to democratize vision care. The company has achieved significant milestones in the development and deployment of their technology, earning recognition for its potential to transform the eye care industry. The impact of Eyebot's innovations is evident in the increased accessibility and convenience of eye exams, contributing to better overall eye health for diverse populations.

Eyebot - Similar Companies

Quadrant Eye logo

Quadrant Eye

EyeQue logo

EyeQue

eyeque.com

EyeNetra logo

EyeNetra

eyenetra.com

Smart Vision Labs logo

Smart Vision Labs

Eyenuk logo

Eyenuk

eyenuk.com

OculoMotor Technologies logo

OculoMotor Technologies

Eye2021 logo

Eye2021

eye2021.com

EyeGage logo

EyeGage

eyegage.com

RightEye logo

RightEye

righteye.com

OptometRx logo

OptometRx

Retina Technologies logo

Retina Technologies

Blink Technologies logo

Blink Technologies

Eyedaptic logo

Eyedaptic

eyedaptic.com

Bioxytech Retina logo

Bioxytech Retina

bioxytech.com

Vivid Vision logo

Vivid Vision

seevividly.com

Eyebot - Quick Facts

Who are Eyebot's competitors?

Companies similar to Eyebot include Quadrant Eye, EyeQue, EyeNetra and Smart Vision Labs.

When was Eyebot founded?

Eyebot was founded in 2021.

Where is Eyebot's headquarters located?

Eyebot's headquarters is located in Boston, MA, US.

When was Eyebot's last funding round?

Eyebot's most recent funding round was for $1M (USD) in September 2023.

How much has Eyebot raised to-date?

As of Sep 7, 2023, Eyebot has raised a total of $3.6M (USD).

How many employees does Eyebot have?

Eyebot has 6 employees as of Feb 4, 2024.

Eyebot - Classification

Industry
  • Hardware
Ownership
  • Venture Capital
Technology
  • Telemedicine
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Consumers
Main Product
  • Eye Exams
  • Vision Care
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software